Literature DB >> 23255859

Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years.

Joon Kee Lee1, Joon Young Seok, Joon Ho Lee, Eun Hwa Choi, Ji Hoon Phi, Seung-Ki Kim, Kyu-Chang Wang, Hoan Jong Lee.   

Abstract

The major aims of this study were to estimate the infection rate and recognize the risk factor for ventriculoperitoneal (VP) shunt infections in children. To analyze shunt infection rate and identify risk factors, a retrospective cohort analysis of 333 consecutive VP shunt series was performed at Seoul National University Children's Hospital in Korea between January 2005 and February 2011. Overall, 35 shunts (10.5%) were infected, which represented an infection rate of 0.075 infection cases per shunt per year. VP shunt infection occurred at a median of 1 month (range, 6 days to 8 months) after insertion. An independent risk factor for shunt infection was undergoing an operation before the first year of life (relative risk 2.31; 95% confidence interval, 1.19-4.48). The most common causative microorganism was coagulase-negative staphylococci in 16 (45.7%) followed by Staphylococcus aureus in 8 (22.9%). Methicillin resistance rate was 83.3% among coagulase-negative staphylococci and S. aureus. In this study, cerebrospinal fluid shunt infection rate was 10.5%. Infection was frequently caused by methicillin-resistant coagulase-negative staphylococci and S. aureus within two months after shunt surgery. Vancomycin may be considered as the preoperative prophylaxis for shunt surgery in a situation where methicillin resistance rate is very high.

Entities:  

Keywords:  Child; Infection; Prophylaxis; Ventriculoperitoneal Shunt

Mesh:

Substances:

Year:  2012        PMID: 23255859      PMCID: PMC3524439          DOI: 10.3346/jkms.2012.27.12.1563

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  22 in total

Review 1.  Surgery of hydrocephalus: past, present and future.

Authors:  J F Hirsch
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Predictors of ventriculoperitoneal shunt pathology.

Authors:  D McClinton; C Carraccio; R Englander
Journal:  Pediatr Infect Dis J       Date:  2001-06       Impact factor: 2.129

3.  Vancomycin use in pediatric neurosurgery patients.

Authors:  S S Shah; R L Sinkowitz-Cochran; H L Keyserling; W R Jarvis
Journal:  Am J Infect Control       Date:  1999-12       Impact factor: 2.918

4.  Improving survival of vulnerable infants increases neonatal intensive care unit nosocomial infection rate.

Authors:  N Zafar; C M Wallace; P Kieffer; P Schroeder; M Schootman; A Hamvas
Journal:  Arch Pediatr Adolesc Med       Date:  2001-10

5.  Repeat cerebrospinal fluid shunt infection in children.

Authors:  A V Kulkarni; D Rabin; M Lamberti-Pasculli; J M Drake
Journal:  Pediatr Neurosurg       Date:  2001-08       Impact factor: 1.162

6.  CSF shunt infections in children.

Authors:  U Kontny; B Höfling; P Gutjahr; D Voth; M Schwarz; H J Schmitt
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

7.  CSF shunt infections in pediatrics. A seven-year experience.

Authors:  C Odio; G H McCracken; J D Nelson
Journal:  Am J Dis Child       Date:  1984-12

8.  Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.

Authors:  E Tacconelli; M A Cataldo; A Albanese; M Tumbarello; E Arduini; T Spanu; G Fadda; C Anile; G Maira; G Federico; R Cauda
Journal:  J Hosp Infect       Date:  2008-07-07       Impact factor: 3.926

9.  Ventriculoperitoneal shunt infections with gram-negative bacteria.

Authors:  J K Stamos; B A Kaufman; R Yogev
Journal:  Neurosurgery       Date:  1993-11       Impact factor: 4.654

10.  Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.

Authors:  Matthew J McGirt; Aimee Zaas; Herbert E Fuchs; Timothy M George; Keith Kaye; Daniel J Sexton
Journal:  Clin Infect Dis       Date:  2003-03-18       Impact factor: 9.079

View more
  20 in total

1.  Predicting ventriculoperitoneal shunt infection in children with hydrocephalus using artificial neural network.

Authors:  Zohreh Habibi; Abolhasan Ertiaei; Mohammad Sadegh Nikdad; Atefeh Sadat Mirmohseni; Mohsen Afarideh; Vahid Heidari; Hooshang Saberi; Abdolreza Sheikh Rezaei; Farideh Nejat
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

Review 2.  Prophylactic antibiotics in pediatric neurological surgery.

Authors:  Friederike Knerlich-Lukoschus; Martina Messing-Jünger
Journal:  Childs Nerv Syst       Date:  2018-06-16       Impact factor: 1.475

3.  Microbiology and treatment of cerebrospinal fluid shunt infections in children.

Authors:  Daniel J Adams; Michael Rajnik
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

4.  Abdominal pseudocyst development in a peritoneal dialysis patient with a ventriculoperitoneal shunt: an indication for switch to hemodialysis?

Authors:  Zafer Ercan; Tolga Yildirim; Ozgur Merhametsiz; Ozlem Yayar; Ayhan Haspulat; Mehmet Deniz Ayli
Journal:  Perit Dial Int       Date:  2014-06       Impact factor: 1.756

5.  Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.

Authors:  Giovanni Raffa; Lucia Marseglia; Eloisa Gitto; Antonino Germanò
Journal:  Childs Nerv Syst       Date:  2015-03-28       Impact factor: 1.475

6.  The role of intraventricular antibiotic therapy in the treatment of ventriculo-peritoneal shunt infection in children.

Authors:  Ayse Sahin; Nazan Dalgic; Mustafa Kilic; Pinar Kirgiz; M Kemal Kanik; Ersoy Oz; Adem Yilmaz
Journal:  Childs Nerv Syst       Date:  2021-03-17       Impact factor: 1.475

7.  Actions of N-acetylcysteine, daptomycin, vancomycin, and linezolid on methicillin-resistant Staphylococcus aureus biofilms in the ventriculoperitoneal shunt infections: an experimental study.

Authors:  Tuba Kuruoglu; Gamze Altun; Enis Kuruoglu; Derya Bayırlı Turan; Mehmet Emin Önger
Journal:  Chin Neurosurg J       Date:  2022-07-05

Review 8.  Antimicrobial treatment options for neurosurgical ventricular shunt infections in children from 1993 to 2012: a systematic review.

Authors:  Richard J Drew; Theresa S Cole; Maggie K Lee; Stéphane Paulus; Conor L Mallucci; Andrew Riordan
Journal:  Childs Nerv Syst       Date:  2013-12-10       Impact factor: 1.475

9.  Staphylococcus aureus sarA regulates inflammation and colonization during central nervous system biofilm formation.

Authors:  Jessica N Snowden; Matt Beaver; Karen Beenken; Mark Smeltzer; Alexander R Horswill; Tammy Kielian
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

10.  Quality of Life Among Children Who Had Undergone Ventriculoperitoneal Shunt Surgery.

Authors:  Priyanka Prakash; Manju Dhandapani; Sandhya Ghai; Neena V Singh; Sivashanmugam Dhandapani
Journal:  J Pediatr Neurosci       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.